The FDA and Compounding Pharmacies

Published Online: Wednesday, October 23, 2013
Follow Pharmacy_Times:
In this video, shot at the National Community Pharmacists Association 115th Annual Convention in Orlando, David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists, discusses the roles of the FDA and state boards of pharmacy in regulating compounding pharmacies.

Related Articles
At Burmans Pharmacy, the key to extending the spirit of American Pharmacists Month is to continually improve pharmacy operations.
Vince Canzanese, RPh, director of compounding at Burmans Pharmacy discusses some of the hot topics at the Brookhaven, Pennsylvania independent pharmacy.
Expanding upon efforts to implement the federal Drug Quality and Security Act enacted 1 year ago, the FDA today released 3 policy documents that assist companies that compound sterile drugs with registering as outsourcing facilities.
After the Drug Enforcement Administration revoked the Tampa-based pharmacy’s registration to sell controlled substances and seized its drugs, the company fought back with a lawsuit.
Latest Issues
$auto_registration$